$HELE investors filed a claim against Helen of Troy for allegedly overstating the progress and benefits of Project Pegasus while the restructuring plan lacked enough resources and budget to meet its goals.
After Helen of Troy reported weaker sales, sharply lower adjusted earnings, business disruptions, and continuing cost headwinds, $HELE fell 25.0% on October 9, 2025.
$HELE investors can join this case to be notified about potential recovery.
Between April 24, 2024 and October 8, 2025, Helen of Troy told investors Project Pegasus was generating savings that could be reinvested into brands, growth opportunities, and business capabilities. Executives emphasized that the restructuring plan was on track, improving efficiency, simplifying the supplier base, supporting gross margin expansion, and creating a stronger operating structure.
However, during this period, investors allege Project Pegasus was not delivering the savings, efficiency, or effectiveness the company described. Helen of Troy allegedly failed to disclose that the company lacked enough resources and budget to achieve its restructuring goals. Project Pegasus was not on track to deliver the promised savings and efficiency gains, and the company’s structure had become too complicated, slow, and unfocused.
Then, on July 9, 2024, the company reported first-quarter fiscal 2025 results, including a 49% year-over-year earnings decline and a full-year revenue outlook reduction of more than 20%.
$HELE fell 27.7%, closing at $64.42. Additional revelations followed on May 2, 2025 and July 10, 2025, including the sudden departure of CEO Noel Geoffroy, an 11% net sales decline, nearly 60% lower adjusted earnings per share, and a $414.4 million goodwill impairment.
By October 9, 2025, shares had dropped to $20.70, representing a total decline of 76.8% over the correction period.
Based on these events, $HELE investors filed a claim against Helen of Troy, alleging the company:
It overstated Project Pegasus’s progress and benefits.
It hid that the restructuring plan lacked the resources and budget needed to meet its goals.
It caused investors to reassess Helen of Troy when weaker results, leadership disruption, and cost problems emerged.
Investors argue Helen of Troy misled the market about Project Pegasus and the company’s ability to deliver sustainable savings and efficiency gains, causing losses when the truth emerged.